WallStreetZenWallStreetZen

NASDAQ: ITOS
Iteos Therapeutics Inc Stock Ownership - Who owns Iteos Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Iteos Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Michel DetheuxChief Executive Officer2025-06-1043,883$10.02
$439.71kSell
Michel DetheuxChief Executive Officer2025-06-1043,883$4.30
$188.70kBuy
Michel DetheuxChief Executive Officer2025-06-108,400$10.02
$84.17kSell
Michel DetheuxChief Executive Officer2025-06-108,400$4.30
$36.12kBuy
Michel DetheuxChief Executive Officer2025-06-1094,027$4.30
$404.32kBuy
Michel DetheuxChief Executive Officer2025-06-1018,000$4.30
$77.40kBuy
Michel DetheuxChief Executive Officer2025-06-098,400$4.30
$36.12kBuy
Michel DetheuxChief Executive Officer2025-06-098,400$10.03
$84.25kSell
Michel DetheuxChief Executive Officer2025-06-0943,882$4.30
$188.69kBuy
Michel DetheuxChief Executive Officer2025-06-0943,882$10.03
$440.14kSell

1 of 4

ITOS insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ITOS insiders and whales buy or sell their stock.

ITOS Shareholders

What type of owners hold Iteos Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ecor1 Capital LLC24.18%10,688,978$109.03MInsider
Ecor1 Capital LLC24.18%10,688,978$109.03MInstitution
Mpm Bioventures 2018 LP11.41%5,043,895$51.45MInsider
Mpm Bioventures 2014 LP11.41%5,043,895$51.45MInsider
Blackrock Inc10.35%4,574,537$46.66MInstitution
Tang Capital Management LLC8.66%3,826,692$39.03MInstitution
Ansbert Gadicke7.81%3,452,797$35.22MInsider
Boxer Capital LLC6.67%2,946,915$30.06MInsider
Aaron I. Davis5.04%2,226,301$22.71MInsider
Ra Capital Management LP4.40%1,943,498$19.82MInsider

1 of 3

ITOS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ITOS54.15%45.85%Net BuyingNet Buying
RGNX77.00%23.00%Net SellingNet Selling
ERAS71.72%28.28%Net Buying
PRTC0.15%0.00%
SLDB55.70%44.30%Net Buying
View Top Biotech Stocks

Iteos Therapeutics Stock Ownership FAQ

Who owns Iteos Therapeutics?

Iteos Therapeutics (NASDAQ: ITOS) is owned by 85.40% institutional shareholders, 72.30% Iteos Therapeutics insiders, and 0.00% retail investors. Ecor1 Capital LLC is the largest individual Iteos Therapeutics shareholder, owning 10.69M shares representing 24.18% of the company. Ecor1 Capital LLC's Iteos Therapeutics shares are currently valued at $108.92M.

If you're new to stock investing, here's how to buy Iteos Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.